Summer 2018, CEO greeting – and summer contact details
Dear Customer, Summer is arriving in Sweden and the staff at Inhalation Sciences will be off on well-deserved annual leave at various time points during July and August….
News
Inhalation Sciences’ new CEO in revealing first broadcast interview
”We’ve built up our pipeline of leads from 20 or 30 – to 80, of those I think we have 8 really hot leads”. Meet new ISAB CEO…
Inhalation Sciences’ new CEO in revealing first broadcast interview
”We’ve built up our pipeline of leads from 20 or 30 – to 80, of those I think we have 8 really hot leads”. Meet new ISAB CEO…
Inhalation Sciences evaluating final data in profitable EU antibiotic resistance project FORMAMP
EU authorities have approved and released a final payment of 2 MSEK to ISAB for its four-year work on the FORMAMP project. The project has been profitable scientifically…
Inhalation Sciences’ new CEO Lena Heffler: science, sales, win-win
In her last CEO role Lena Heffler tripled the number of customers for a blood cancer analysis tool—in just 24 months. Her insight? Reaching out to a new,…
New poster, new data, new solutions: Join ISAB at RDD 2018
Meet Mikael Mikko and Mattias Nowenwik, our aerosol generation experts at RDD 2018, April 22-26, Tucson Arizona. Whatever your challenge Mikael and Mattias can offer insight, experience and…
Inhalation Sciences lämnar förtydligande avseende noteringen av Ziccum AB.
Den 15:e mars lämnade Inhalation Sciences en uppdatering av planerna för notering av Ziccum AB. Till följd av de frågor som ställdes i samband med bolagets presentation på…
Inhalation Sciences bjuder in till bolagspresentation hos Erik Penser Bank AB den 15 mars
Inhalation Sciences bjuder in ägare och investerare till en lunchträff med syftet att ge en uppdatering om Inhalation Sciences samt för första gången presentera Ziccum AB i egen regi. Lunchträffen…
Inhalation Sciences technology behind 5 research posters at 2018’s Society of Toxicology (SOT) Annual conference
Inhalation Sciences technology was instrumental to the research of five scientific posters at SOT, San Antonio, US, March 11-15, including three abstracts from Karolinska Institutet (KI) Institute of…
Inhalation Sciences drives commercialization with new recruitment and reorganisation
Inhalation Sciences (ISAB) has recruited a new Product Engineer as part of ongoing commercialization. KTH Royal Institute of Technology graduate Joel Mared joins the lab team in Stockholm….
